Jeffrey S. Heier
Chief Scientific Officer at Ocular Therapeutix, Inc (OCUL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | OCULOcular Therapeutix, Inc | Sell Plan | 10,869307,457 held (−3%) | $7.05 | $77K | +7.0% |
| Aug 26SEC | OCULOcular Therapeutix, Inc | Sell Plan | 3,296318,326 held (−1%) | $10.78 | $36K | -30.1% |
| May 28SEC | OCULOcular Therapeutix, Inc | Sell Plan | 3,018320,350 held (−1%) | $8.20 | $25K | -8.0% |
| Feb 25SEC | OCULOcular Therapeutix, Inc | Sell Plan | 3,057323,368 held (−1%) | $8.28 | $25K | -8.9% |
| Nov 26SEC | OCULOcular Therapeutix, Inc | Sell Plan | 3,469245,940 held (−1%) | $12.04 | $42K | -37.4% |
| Oct 6SEC | OCULOcular Therapeutix, Inc | Sell Plan | 10,502249,409 held (−4%) | $11.04 | $116K | -31.7% |
- Sell
Chief Scientific Officer Jeffrey S. Heier sold $77K of OCUL at $7.05 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S. Heier sold $36K of OCUL at $10.78 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S. Heier sold $25K of OCUL at $8.20 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S. Heier sold $25K of OCUL at $8.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S. Heier sold $42K of OCUL at $12.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S. Heier sold $116K of OCUL at $11.04 — pre-scheduled 10b5-1 plan sale.